Dr. Marignani joins Creative Destruction Lab (CDL) Prime as a Mentor Scientist and Strategist
December 1, 2021
Interview on CKDU 88.1 FM: Dalhousie receives $250,000 for precision oncology research from Breast Cancer Society of Canada
June 20, 2022
Dr. Paola Marignani to identify unique markers associated with HER2+ breast cancer recurrence
The Breast Cancer Society of Canada has announced $250,000 in funding to the Department of Biochemistry and Molecular Biology, Faculty of Medicine at Dalhousie University, for a research project led by Dr. Paola Marignani. The project aims to identify unique markers associated with HER2+ breast cancer recurrence at the single-cell level.
About one third of all breast cancers are classified as HER2-positive due to high levels of the HER2 cell surface protein. Drugs that target HER2 have been successful, however this type of cancer returns at a high frequency once treatment has been completed. The overarching goal of the research project is to identify new biomarkers that distinguish recurrence potential from HER2+ breast cancer.
Read the full article at https://breastcancerprogress.ca/250000-grant-to-dr-paola-marignani-to-identify-her2-markers/